A bitter pill to swallow?

Article Abstract:

UK companies in April 2004 are focusing on the requirements of all European listed firms to adopt International Financial Reporting Standards (IFRS), and all the challenges that conversion to IFRS presents. The pharmaceutical sector faces issues such as research and development (R&D), product licensing and other revenue recognition matters, and would also be sensitive to general areas such as employee compensation and upcoming changes in accounting for mergers and acquisitions.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

What FDs think

Article Abstract:

Finance directors are worried about the international accounting standard-setting process, but they also have the capacity to influence the creation of quality standards in future. Many research reports have revealed that the UK finance directors are ready to support the International Financial Reporting Standards (IFRS) convergence on their own terms.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Big bath for pensions?

Article Abstract:

Retirement benefits may suffer under the new accounting standard, which companies have until Jun 03 to implement. Boots Co. PLC shifted its pension funds to bonds to avoid volatility.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: